Signs of Stigma and Poor Mental Health Among Carriers of Methicillin-Resistant Staphylococcus aureus

Rump, Babette; Boer, Mark G J de; Reis, Ria; Wassenberg, M.W.M.; Steenbergen, Jim van

doi:10.1093/ofid/ofw172.175

Cited by 2 publications

(4 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…5 Not least since the downsides for individual patients may be assumed to be similar (see further below). The current Swedish policy to screen for MRSA has been successful in containing the spread of hospital acquired infections, but not uncontroversial (Diekema and Climo 2008;Skyman et al 2010;Skyman 2014;Rump 2016;Wenzel et al 2008;Edmond et al 2008). Before moving on to our main point, we will first give a short critical appraisal of the screening programme for MRSA and the considerations that play a role in structuring the policy.…”

Section: Ethics and Effectivenessmentioning

confidence: 99%

“…In Sweden, like in other Scandinavian countries and the Netherlands, screening programmes have been set up to minimize transmission of pathogenic bacteria and to prevent hospital outbreaks. In-hospital restrictions in case of a positive test are quite burdensome, involving isolation and intensified hygiene measures (Rump 2016;Socialstyrelsen 2010). Furthermore, upon release, patients in Sweden are bound by law to take precautions in their daily life (for instance, with respect to family members (Skyman 2014).…”

Section: Ethics and Effectivenessmentioning

confidence: 99%

“…Patients remain registered as a carrier of MRSA, until they repeatedly test negative. 7 The negative effects of being classified as carrier, especially MRSA carriership, and the subsequent contact precautions have been extensively described (Skyman 2010(Skyman , 2014Rump 2016). MDR bacteria are scary, particularly if (as is frequently the case in public campaigns and media portrayals) advertised as 'superbugs', or even 'killer bugs'.…”

Section: Ethics and Effectivenessmentioning

confidence: 99%

“…It may also fuel irrational and unnecessary fears in both patients and healthcare workers. As a consequence, patients form their own strategies to cope with the contagion limiting their social contacts in daily life and they may become overly worried, stressed and even depressed (Rump 2016;Skyman 2010Skyman , 2014. In addition, healthcare providers, family members and society as a whole may also respond to a positive test with unfounded fear and anxiety, leading to discrimination, exclusion and other stigmatizing behaviour (Wiklund et al 2013(Wiklund et al , 2015Skyman 2014).…”

Section: Ethics and Effectivenessmentioning

confidence: 99%

See 3 more Smart Citations

Screening for multi-drug-resistant Gram-negative bacteria: what is effective and justifiable?

Nijsingh

Munthe

Lindblom

et al. 2020

Monash Bioeth. Rev.

View full text Add to dashboard Cite

Effectiveness is a key criterion in assessing the justification of antibiotic resistance interventions. Depending on an intervention's effectiveness, burdens and costs will be more or less justified, which is especially important for large scale populationlevel interventions with high running costs and pronounced risks to individuals in terms of wellbeing, integrity and autonomy. In this paper, we assess the case of routine hospital screening for multi-drug-resistant Gram-negative bacteria (MDRGN) from this perspective. Utilizing a comparison to screening programs for Methicillin-Resistant Staphylococcus aureus (MRSA) we argue that current screening programmes for MDRGN in low endemic settings should be reconsidered, as its effectiveness is in doubt, while general downsides to screening programs remain. To accomplish justifiable antibiotic stewardship, MDRGN screening should not be viewed as a separate measure, but rather as part of a comprehensive approach. The program should be redesigned to focus on those at risk of developing symptomatic infections with MDRGN rather than merely detecting those colonised.

show abstract

Section: Ethics and Effectivenessmentioning

confidence: 99%

Section: Ethics and Effectivenessmentioning

confidence: 99%

Section: Ethics and Effectivenessmentioning

confidence: 99%

Section: Ethics and Effectivenessmentioning

confidence: 99%

See 2 more Smart Citations

Screening for multi-drug-resistant Gram-negative bacteria: what is effective and justifiable?

Nijsingh

Munthe

Lindblom

et al. 2020

Monash Bioeth. Rev.

View full text Add to dashboard Cite

show abstract

Conceptualizing the Impact of MDRO Control Measures Directed at Carriers: A Capability Approach

Byskov

Rump

Verweij

2020

Ethics and Drug Resistance: Collective Responsibility for Global Public Health

View full text Add to dashboard Cite

Many countries have implemented specific control measures directed at carriers of multidrug-resistant organisms (MDRO) in order to prevent further introduction and transmission of resistant organisms into hospitals and other healthcare related settings. These control measures may in many ways affect the lives and well-being of carriers of MDRO, resulting in complex ethical dilemmas that often remain largely implicit in practice. In this chapter, we propose to conceptualize the impact of MDRO control measures on the well-being of individual carriers in terms of capabilities and functionings. A capabilitarian framework for the ethical treatment of MDRO carriers commits us to conceptualize the harm done to carriers in terms of the impact that MDRO control measures have on what they are able to do or be. Adopting and adapting Nussbaum’s list of ten central human capabilities, we present a taxonomy of capabilities and functionings that are normatively relevant for the design and evaluation of MDRO control measures.

show abstract

Signs of Stigma and Poor Mental Health Among Carriers of Methicillin-Resistant Staphylococcus aureus

Cited by 2 publications

References 0 publications

Screening for multi-drug-resistant Gram-negative bacteria: what is effective and justifiable?

Screening for multi-drug-resistant Gram-negative bacteria: what is effective and justifiable?

Conceptualizing the Impact of MDRO Control Measures Directed at Carriers: A Capability Approach

Contact Info

Product

Resources

About